Breaking News

EU negotiates purchase of more vaccines

The European Commission has approached the Pfizer / BioNTech laboratories to request 100 million additional doses of the only vaccine currently authorized in the Union.

The European Commission has approached the Pfizer / BioNTech laboratories to request 100 million additional doses of the only vaccine currently authorized in the Union.

The European states finding themselves confronted with popular pressure on the slowness in the supply of anti-covid vaccines, it is towards the Commission that the governors are now turning. Asking the authority responsible for centralizing serum requests in a global order to have more vaccine possibilities, and that quickly. Thus, the European Union is currently negotiating with Pfizer Inc. and BioNTech SE an agreement that could double their supply in anti-covid vaccines.

The new contract would include 100 million doses, as well as’an option for 200 million additional doses. The question seems all the more pressing as the epidemic continues to claim many infections and victims in Europe. At the last assessment, Europe totaled 589,554 deaths linked to the infection for 27 million positive cases detected.

But above all, the Old Continent – via the European Medicines Agency – is slow to validate compositions other than the one approved on December 21 from the two Pfizer / BioNTech laboratories. At best, doses of AstraZeneca Plc will not be available for several weeks at the earliest. And even if EMA gives a favorable opinion, Wednesday.

The attempt to obtain a larger quantity of the Pfizer-BioNTech vaccine comes less than a week after the 27 member states increased their initial order to 300 million (which was then limited to 200 million doses). If the option of the new deal were exercised, it would bring the total number of doses to 600 million. Is enough for vaccinate two thirds of the population Union on the basis of a two-injection scheme.

The EU has also signed agreements with a number of pharmaceutical companies to gain access to nearly 2 billion doses.

On the Luxembourg side, officially, the country is sticking to the only order made with the European Commission. But in a recent interview with Paperjam, Dr. Jean-Claude Schmitt did not hide that the country had “signaled to various firms an interest in possibly negotiating a purchase of additional doses of vaccine. But nothing was discussed or signed. ” In other words, the Health Directorate is also stalking – discreetly – the means of obtaining supplies differently than the Commission circuit.

One certainty: for the time being, the Grand Duchy has the means to carry out the vaccination (1st injection and booster) for 36,000 people. These are doses delivered by the Pfizer factory in Belgium, like the first delivery received on December 26.


Tags

Related Articles

Back to top button
Close
Close